https://orcid.org/0000-0002-3997-676X
References
- Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–2128. doi:10.1016/S0140-6736(12)61728-0
- Mathers CD, Loncar D. Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med. 2006;3(11):e442. doi:10.1371/journal.pmed.0030442
- Tabor PA, Lopez DA. Comply with us: improving medication adherence. J Pharm Pract. 2004;17:167–181. doi:10.1177/0897190004264816
- Osterberg L, Blaschke T. Drug therapy: adherence to medication. N Engl J Med. 2005;353:487–497. doi:10.1056/NEJMra050100
- Van Boven JF, Chavannes NH, Van Der Molen T, et al. Clinical and economic impact of non-adherence in COPD: a systemic review. Respir Med. 2014;108(1):103–113. doi:10.1016/j.rmed.2013.08.044
- Kokturk N, Polatli M, Oguzulgen IK, et al. Adherence to COPD treatment in Turkey and Saudi Arabia: results of the ADCARE study. Int J COPD. 2018;13:1377–1388. doi:10.2147/COPD.S150411
- Ingebrigtsen TS, Marott JL, Nordestgaard BG, et al. Low use and adherence to maintenance medication in chronic obstructive pulmonary disease in the general population. J Gen Intern Med. 2015;30(1):51–59. doi:10.1007/s11606-014-3029-0
- Galal I, Mohammad Y, Nada A, Mohran Y. Medication adherence and treatment satisfaction in some Egyptian patients with chronic obstructive pulmonary disease and bronchial asthma. Egyptian Journal of Broncholog. 2018;12:1.
- Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease; 2018. Available from: www.goldcopd.org. Accessed April 3, 2023.
- Alamoudi O, Attar S, Ghabrah T, Al-Qassimi M. Pattern of common diseases in hospitalized patients at an university hospital in Saudi Arabia; A Study of 5594 Patients. JKAU Med Sci. 2009;16(4):3–12.
- Al Shammari S. Determinants of the length of patient stay in hospital in Saudi Arabia. Saudi Med J. 1996;17(6):709–717.
- Krauskopf K, Federman AD, Kale MS, et al. Chronic obstructive pulmonary disease illness and medication beliefs are associated with medication adherence. COPD. 2015;12(2):151–164. doi:10.3109/15412555.2014.922067
- Simoni-Wastila L, Wei Y-J, Qian J, et al. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hos- pitalization and spending in a Medicare population. Am J Geriatr Pharmac. 2012;10(3):201e210.
- Toy EL, Beaulieu NU, McHale JM, et al. Treatment of COPD: relationships between daily dosing frequency, adherence, resource use, and costs. Respir Med. 2011;105(3):435e441.
- Cecere LM, Slatore CG, Uman JE, et al. Adherence to long-acting inhaled therapies among patients with chronic obstructive pulmonary disease (COPD). COPD J Chronic Obstr Pulm Dis. 2012;9(3):251e258.
- Sayiner A, Alzaabi A, Obeidat NM, et al. Attitudes and beliefs about COPD: data from the BREATHE study. Respir Med. 2012;106(Suppl 2):S60–S74. doi:10.1016/S0954-6111(12)70015-X
- Restrepo RD, Alvarez MT, Wittnebel LD, et al. Medication adherence issues in patients treated for COPD. Int J Chron Obstruct Pulmon Dis. 2008;3(3):371e384. doi:10.2147/COPD.S3036
- Albrecht JS, Khokhar B, Huang TY, et al. Adherence and healthcare utilization among older adults with COPD and depression. Respir Med. 2017;129:53–58. PMID: 28732836; PMCID: PMC5607946. doi:10.1016/j.rmed.2017.06.002
- Vestbo J, Anderson JA, Calverley PM, et al. Adherence to inhaled therapy, mortality and hospital admission in COPD. Thorax. 2009;64(11):939–943.